The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...

Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...

And sometimes you can find stocks that are especially great bargains. Three Motley Fool contributors believe they've done just that. Here's ...

MODERNA INC (MRNA) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 86% based on the firm’s underlying fundamentals and the stock’s valuation.

The research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

In the early 1990s, Katalin Karikó was obsessed with an idea most of her fellow scientists dismissed: Could messenger RNA, or ...

Detailed price information for Arcturus Therapeutics Ltd (ARCT-Q) from The Globe and Mail including charting and trades.

Why are those on the left so angry? It doesn’t seem to matter if it is an anti-Israel protest or hatred directed towards Elon ...

Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the ...

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen ...